Schizophrenia

Schizophrenia is a brain condition that may cause auditory and/or visual hallucinations, delusions, difficulties with emotions and cognition, and verbal communication problems. These symptoms manifest between the ages of 16 and 30.

Quick Answer

What it is

Schizophrenia is a brain condition that may cause auditory and/or visual hallucinations, delusions, difficulties with emotions and cognition, and verbal communication problems. These symptoms manifest between the ages of 16 and 30.

Key findings

  • Grade A: Schizophrenia symptoms (Sarcosine)
  • Grade B: Cognition (D-Serine)
  • Grade B: Apolipoprotein B (Berberine)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Schizophrenia

  • Supplements Studied:21
  • Research Trials:30
  • Total Participants:6,952
  • Grade A Supplements:1
  • Top Supplement:Sarcosine (A)
30 trials
6,952 ppts
21 supps · 69 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

2g daily

Glycine transporter-1 inhibitor that enhances NMDA receptor function to improve negative and cognitive symptoms

10 studies | 400 participants
0.4-0.8g/kg/day (typically 30-60g daily)

NMDA receptor co-agonist that enhances glutamatergic neurotransmission to improve negative symptoms

15 studies | 600 participants

Supporting Stack (Tier 2)

30-60mg/kg/day (typically 2-4g daily)

NMDA receptor co-agonist with higher potency than glycine; improves negative and cognitive symptoms

10 studies | 400 participants
2-4g EPA/DHA daily

May improve membrane fluidity and reduce inflammation; modest effects on symptoms and prevention

15 studies | 1,000 participants

Modulates glutamate via cystine-glutamate antiporter and provides antioxidant support

10 studies | 500 participants
2-15mg daily (as L-methylfolate for those with MTHFR variants)

Supports methylation pathways; deficiency common in schizophrenia; may improve negative symptoms

8 studies | 300 participants
2000-4000 IU daily (target 40-60 ng/mL)

Deficiency associated with schizophrenia risk and severity; supports neuroprotection and immune function

8 studies | 400 participants

How It Works

Schizophrenia is a serious mental illness affecting about 1% of the population. While antipsychotic medications effectively treat positive symptoms (hallucinations, delusions), they have limited effect on negative symptoms (social withdrawal, lack of motivation, reduced emotional expression) and cognitive impairment—which significantly impact quality of life. This protocol focuses on supplements that may help with these difficult-to-treat symptoms, always as adjuncts to standard psychiatric care.

IMPORTANT: These supplements are meant to complement, not replace, antipsychotic medications and psychiatric care. Never stop or adjust medications without consulting your psychiatrist.

•Sarcosine is the most promising supplement for schizophrenia. It works by blocking the glycine transporter-1 (GlyT-1), which increases glycine levels at the NMDA receptor. The NMDA receptor hypothesis of schizophrenia suggests that underactivity of this receptor contributes to negative and cognitive symptoms. Studies show sarcosine can improve negative symptoms, cognitive function, and overall functioning when added to antipsychotics. It should NOT be used with clozapine (may reduce clozapine's effectiveness).
•Glycine directly activates the NMDA receptor as a co-agonist. High doses are needed because most glycine doesn't reach the brain. Studies show it can improve negative symptoms when added to antipsychotics (except clozapine). The large doses required (30-60g/day) can be impractical and cause GI issues.
•D-Serine is another NMDA receptor co-agonist, more potent than glycine. It may improve negative and cognitive symptoms. However, there are theoretical concerns about kidney toxicity at high doses (though human studies haven't confirmed this).
•Omega-3 Fatty Acids have shown particular promise in early-stage psychosis and those at ultra-high risk for developing schizophrenia. One landmark study found omega-3s significantly reduced the conversion to full psychosis in at-risk youth. Effects in established schizophrenia are more modest but may help with overall symptom burden.
•N-Acetylcysteine (NAC) modulates glutamate signaling through the cystine-glutamate antiporter and provides powerful antioxidant support. It may help with negative symptoms and reduce the severity of positive symptoms. It's also been studied for improving overall symptom scores.
•Folate/Methylfolate deficiency is common in schizophrenia and may contribute to negative symptoms. Supplementation, particularly with methylfolate (which bypasses the common MTHFR genetic variation), may improve negative symptoms in those with low folate status or specific genetic variants.
•Vitamin D deficiency is very common in schizophrenia (possibly due to reduced sun exposure) and has been linked to both disease risk and severity. While not directly therapeutic, correcting deficiency is reasonable.

Expected timeline: NMDA-targeting supplements (sarcosine, glycine, D-serine) may show effects within 4-8 weeks. NAC: 8-12 weeks. Omega-3s: variable, potentially longer in early intervention. Always monitor symptoms closely with your psychiatric team.

Generated from peer-reviewed researchSchema v2.0

Supplements for Schizophrenia

Sorted by strength of evidence

ASarcosine
2
↓Schizophrenia symptomsImproves↑CognitionImproves
BGlycine
2
↓Schizophrenia symptomsImproves↑CognitionImproves
BD-Serine
1
↑CognitionImproves↓Schizophrenia symptomsImproves
BBerberine
1
↓Apolipoprotein BImproves↓Total cholesterolImproves↑High-density lipoprotein (HDL)Improves
CSaffron
1
↓C-Reactive Protein (CRP)Improves↓Erythrocyte Sedimentation RateImproves↑HematocritImproves
CChromium
1
↓HbA1cImproves↓Schizophrenia symptomsImproves↓WeightImproves
CAshwagandha
1
↓Blood glucoseImproves↓Blood PressureImproves↓C-Reactive Protein (CRP)Improves
CTheanine
1
↓Anxiety SymptomsImproves↓CortisolImproves↑DHEASImproves
CGinkgo Biloba
1
Anti-Oxidant Enzyme Profile↓Schizophrenia symptomsImproves↑Serum BDNFImproves
CPanax Ginseng (Korean Ginseng)
1
↓Depression SymptomsImproves↓Schizophrenia symptomsImproves↑Working MemoryImproves
CFolic Acid (Vitamin B9)
1
↑CognitionImproves↓Schizophrenia symptomsImproves↓Depression SymptomsImproves
DL-Tyrosine
1
Memory↓Schizophrenia symptomsImproves
DVitamin B12
1
Cognition↓Schizophrenia symptomsImproves
DN-Acetylcysteine
1
Processing Speed↓Schizophrenia symptomsImproves↑Working MemoryImproves
DResveratrol
1
Body Fat↓Body Mass Index (BMI)Improves↓WeightImproves
DInositol
1
Depression Symptoms↓Schizophrenia symptomsImproves

Detailed Outcomes

Grade:
Effect:
Size:
Sort:
|
A
Schizophrenia symptoms
Moderate Improvement
4 studies
moderate↓Improves
B
Cognition
Small Improvement
2 studies
small↑Improves
B
Cognition
Small Improvement
3 studies
small↑Improves
C
Schizophrenia symptoms
Small Improvement
6 studies
small↓Improves
B
Schizophrenia symptoms
Small Improvement
2 studies
small↓Improves
C
Cognition
Small Improvement
1 study
small↑Improves
B
Apolipoprotein B
Small Improvement
2 studies
small↓Improves
?
Total cholesterol
15 studies
↓Improves
?
High-density lipoprotein (HDL)
13 studies
↑Improves
?
Low-density lipoprotein (LDL)
12 studies
↓Improves
?
Triglycerides
12 studies
↓Improves
C
C-Reactive Protein (CRP)
Small Decrease
1 study
small↓Improves
?
Erythrocyte Sedimentation Rate
1 study
↓Improves
?
Hematocrit
1 study
↑Improves
?
Hemoglobin
1 study
↑Improves
?
Serum T3
1 study
↑Improves
?
Serum T4
1 study
↑Improves
?
Thyroid-Stimulating Hormone
1 study
↑Improves
?
White Blood Cell Count
1 study
↑Improves
C
HbA1c
Moderate Improvement
1 study
moderate↓Improves
?
Schizophrenia symptoms
1 study
↓Improves
?
Weight
1 study
↓Improves
C
Blood glucose
Small Improvement
1 study
small↓Improves
?
Blood Pressure
1 study
↓Improves
?
C-Reactive Protein (CRP)
1 study
↓Improves
?
Heart Rate
1 study
↓Improves
?
High-density lipoprotein (HDL)
1 study
↑Improves
?
Interleukin 6
1 study
↓Improves
?
Schizophrenia symptoms
1 study
↓Improves
?
Stress Signs and Symptoms
1 study
↓Improves
?
Triglycerides
1 study
↓Improves
?
Weight
1 study
↓Improves
C
Anxiety Symptoms
Small Improvement
1 study
small↓Improves
?
Cortisol
1 study
↓Improves
?
DHEAS
1 study
↑Improves
?
Insulin
1 study
↑Worsens
?
Schizophrenia symptoms
1 study
↓Improves
?
Serum BDNF
1 study
↑Improves
?
Serum DHEA
1 study
↑Improves
?
Subjective Well-Being
1 study
↑Improves
?
Total cholesterol
1 study
↓Improves
C
Anti-Oxidant Enzyme Profile
Mixed effect
1 study
?
Schizophrenia symptoms
4 studies
↓Improves
?
Serum BDNF
1 study
↑Improves
?
Tardive Dyskinesia Symptoms
1 study
↓Improves
C
Depression Symptoms
Small Improvement
1 study
small↓Improves
?
Schizophrenia symptoms
1 study
↓Improves
?
Working Memory
1 study
↑Improves
C
Cognition
Small Improvement
1 study
small↑Improves
?
Schizophrenia symptoms
7 studies
↓Improves
?
Depression Symptoms
1 study
↓Improves
D
Body Fat
No effect
8 studies
none
?
Body Mass Index (BMI)
25 studies
↓Improves
?
Weight
23 studies
↓Improves
?
Waist circumference
11 studies
↓Improves
D
Processing Speed
No effect
3 studies
none
?
Schizophrenia symptoms
5 studies
↓Improves
?
Working Memory
3 studies
↑Improves
D
Memory
No effect
1 study
none
?
Schizophrenia symptoms
1 study
↓Improves
D
Cognition
No effect
1 study
none
?
Schizophrenia symptoms
1 study
↓Improves
D
Depression Symptoms
No effect
1 study
none
?
Schizophrenia symptoms
3 studies
↓Improves
?
Schizophrenia symptoms
14 studies
↓Improves
?
C-Reactive Protein (CRP)
4 studies
↓Improves
?
Schizophrenia symptoms
2 studies
↓Improves
?
Oxidative Stress Biomarkers
1 study
↓Improves
?
Schizophrenia symptoms
1 study
↓Improves

Research Citations (100)

Effects of omega-3 fatty acids on chronic pain: a systematic review and meta-analysis.
(2025)
PMID: 41267881
The effects of probiotic supplementation on cardiometabolic health in patients with prediabetes: a systematic review, meta-analysis, and GRADE assessment.
(2025)
PMID: 40959695
Lactococcus lactis strain Plasma activates plasmacytoid dendritic cells and mitigates common cold-like symptoms in healthy adults: a meta-analysis of individual participant data.
(2025)
PMID: 41280892
Effects of Withania somnifera supplementation on cognitive function: A systematic review and meta-analysis
(2024)
PMID: 38146803
Effects of Ashwagandha (Withania somnifera) Supplementation on Exercise Performance: A Systematic Review and Meta-Analysis
(2024)
PMID: 38529566
Ashwagandha (Withania somnifera) and its withanolides attenuate oxidative and inflammatory signaling in the nervous system
(2024)
PMID: 38678538
Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis of randomized controlled trials
(2023)
PMID: 36804187
Clinical effects of Ashwagandha (Withania somnifera) root extract on human health: A systematic review of reviews
(2023)
PMID: 37062481
A Comprehensive Review on Pharmacological Activity of Withania somnifera (Ashwagandha)
(2023)
PMID: 37234185
Effects of Ashwagandha (Withania somnifera) on Testosterone Levels: A Systematic Review and Meta-Analysis
(2022)
PMID: 35371298

Related Conditions

Metabolic Health

14 shared supplements · 975 outcomes

Research on metabolism, blood glucose regulation, insulin sensitivity, and metabolic syndrome.

14 shared supplements · outcomes

Depression

13 shared supplements · 98 outcomes

Depression is a chronic state of low mood often associated with hopelessness, apathy, and fatigue. Unlike sadness, depression is a disorder that persists for weeks or months and interferes with daily life.

Type 2 Diabetes

12 shared supplements · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Cognitive Improvement

12 shared supplements · 324 outcomes

Cognitive improvement refers to an increase in performance on tasks of mental abilities including learning, thinking, memory, problem solving, logical reasoning, decision making, and attention.

Overweight

10 shared supplements · 379 outcomes

Overweight is characterized as having a body mass index (BMI) of 25 to 29.9. Having overweight is associated with increased risk of conditions such as cardiovascular disease. However, this may not be the case in people with increased lean mass (e.g., athletes or weight lifters).

Obesity

10 shared supplements · 525 outcomes

Obesity is a condition of excessive body fat that increases the risk for other conditions such as diabetes and heart disease. Fat is how the body stores extra calories that were eaten but not used. Obesity treatment usually involves restricting the calories eaten or creating a negative calorie balance.

Mood Improvement

10 shared supplements · 159 outcomes

Mood improvement refers to a beneficial change in one’s temporary mental or emotional state which can include improvements in feelings of anxiety, anger, sadness, relief, positivity, optimism, loneliness, insecurity, happiness, excitement, curiosity, and calmness.